Local Anesthetic for Plateau Fractures

Phase 4Not Yet RecruitingNCT06474949

University of Washington100 enrolled

Overview

Subjects may receive an injection at the end of the surgery to fix their broken leg that may reduce their pain and hospital stay

Subjects will be randomized to bupivicaine or saline injection in the joint at the end of Open Reduction Internal Fixation of the tibial plateau fracture

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

100

Conditions

Tibial Plateau Fractures

Interventions

Bupivacaine injectionDRUG

Injection at end of Open Reduction Internal Fixation

SalineOTHER

Injection at end of Open Reduction Internal Fixation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \>=18 year , * tibial plateau fracture undergoing Open Reduction and fixation" Exclusion: * allergy to bupivacaine * Prolonged external fixator use

Outcomes

Primary Outcomes

Pain in the knee visual analogue scale 11 point scale 0(no pain) -10 (worst pain)

Pain at time of visit

Time frame: From date of hospitalization to end of follow-up at 6 months

Secondary Outcomes

Length of stay for hospitalization

Time frame: From date of hospitalization up to one month post surgery

Central Contacts

Julie Agel

CONTACT

206.744.4113 bagel@uw.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.